Company registration number 01080540 (England and Wales)
BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
PAGES FOR FILING WITH REGISTRAR
BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
BALANCE SHEET
AS AT
31 DECEMBER 2023
31 December 2023
- 1 -
2023
2022
Notes
£
£
£
£
Fixed assets
Intangible assets
3
1,474
1,684
Tangible assets
4
1,207
195
2,681
1,879
Current assets
Stocks
161,576
166,576
Debtors
5
102,905
108,922
Cash at bank and in hand
51
20,393
264,532
295,891
Creditors: amounts falling due within one year
6
(132,695)
(94,829)
Net current assets
131,837
201,062
Total assets less current liabilities
134,518
202,941
Creditors: amounts falling due after more than one year
7
(14,167)
(24,167)
Net assets
120,351
178,774
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
120,251
178,674
Total equity
120,351
178,774
BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2023
31 December 2023
- 2 -

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 14 May 2025
Mr G Tester
Director
Company Registration No. 01080540
BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
- 3 -
1
Accounting policies
Company information

Be-Well (Health, Dietary & Nutritional) Products Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 20 King Street Industrial Estate, Langtoft, Peterborough, Cambridgeshire, PE6 9NF.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
1
Accounting policies
(Continued)
- 4 -
1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Trademarks
10% straight line
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20-33% straight line
Fixtures & fittings
20% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
1
Accounting policies
(Continued)
- 5 -
1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

The cost of providing benefits under defined benefit plans is determined separately for each plan using the projected unit credit method, and is based on actuarial advice.

 

The change in the net defined benefit liability arising from employee service during the year is recognised as an employee cost. The cost of plan introductions, benefit changes, settlements and curtailments are recognised as an expense in measuring profit or loss in the period in which they arise.

1.10
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.11
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

Government grants relating to turnover are recognised as income over the periods when the related costs are incurred. Grants relating to an asset are recognised in income systematically over the asset's expected useful life. If part of such a grant is deferred it is recognised as deferred income rather than being deducted from the asset's carrying amount.

1.12
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
9
9
BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
- 6 -
3
Intangible fixed assets
Other
£
Cost
At 1 January 2023 and 31 December 2023
2,106
Amortisation and impairment
At 1 January 2023
422
Amortisation charged for the year
210
At 31 December 2023
632
Carrying amount
At 31 December 2023
1,474
At 31 December 2022
1,684
4
Tangible fixed assets
Plant and equipment
Fixtures & fittings
Total
£
£
£
Cost
At 1 January 2023
11,380
6,663
18,043
Additions
1,325
-
0
1,325
At 31 December 2023
12,705
6,663
19,368
Depreciation and impairment
At 1 January 2023
11,379
6,469
17,848
Depreciation charged in the year
265
48
313
At 31 December 2023
11,644
6,517
18,161
Carrying amount
At 31 December 2023
1,061
146
1,207
At 31 December 2022
1
194
195
5
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
14,789
18,802
Other debtors
88,116
90,120
102,905
108,922
BE-WELL (HEALTH, DIETARY & NUTRITIONAL) PRODUCTS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023
- 7 -
6
Creditors: amounts falling due within one year
2023
2022
£
£
Bank loans and overdrafts
23,091
10,000
Trade creditors
28,896
42,554
Taxation and social security
22,202
11,496
Other creditors
58,506
30,779
132,695
94,829
7
Creditors: amounts falling due after more than one year
2023
2022
£
£
Bank loans and overdrafts
14,167
24,167
8
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of £1 each
100
100
100
100
2023-12-312023-01-01falsefalsefalse14 May 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityG TesterMr B M Kilby010805402023-01-012023-12-31010805402023-12-31010805402022-12-3101080540core:IntangibleAssetsOtherThanGoodwill2023-12-3101080540core:IntangibleAssetsOtherThanGoodwill2022-12-3101080540core:PlantMachinery2023-12-3101080540core:ComputerEquipment2023-12-3101080540core:PlantMachinery2022-12-3101080540core:ComputerEquipment2022-12-3101080540core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3101080540core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-3101080540core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3101080540core:Non-currentFinancialInstrumentscore:AfterOneYear2022-12-3101080540core:CurrentFinancialInstruments2023-12-3101080540core:CurrentFinancialInstruments2022-12-3101080540core:ShareCapital2023-12-3101080540core:ShareCapital2022-12-3101080540core:RetainedEarningsAccumulatedLosses2023-12-3101080540core:RetainedEarningsAccumulatedLosses2022-12-3101080540core:ShareCapitalOrdinaryShareClass12023-12-3101080540core:ShareCapitalOrdinaryShareClass12022-12-3101080540bus:Director12023-01-012023-12-3101080540core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3101080540core:PatentsTrademarksLicencesConcessionsSimilar2023-01-012023-12-3101080540core:PlantMachinery2023-01-012023-12-3101080540core:ComputerEquipment2023-01-012023-12-31010805402022-01-012022-12-3101080540core:IntangibleAssetsOtherThanGoodwill2022-12-3101080540core:PlantMachinery2022-12-3101080540core:ComputerEquipment2022-12-31010805402022-12-3101080540core:WithinOneYear2023-12-3101080540core:WithinOneYear2022-12-3101080540core:Non-currentFinancialInstruments2023-12-3101080540core:Non-currentFinancialInstruments2022-12-3101080540bus:OrdinaryShareClass12023-01-012023-12-3101080540bus:OrdinaryShareClass12023-12-3101080540bus:OrdinaryShareClass12022-12-3101080540bus:PrivateLimitedCompanyLtd2023-01-012023-12-3101080540bus:SmallCompaniesRegimeForAccounts2023-01-012023-12-3101080540bus:FRS1022023-01-012023-12-3101080540bus:AuditExemptWithAccountantsReport2023-01-012023-12-3101080540bus:CompanySecretary12023-01-012023-12-3101080540bus:FullAccounts2023-01-012023-12-31xbrli:purexbrli:sharesiso4217:GBP